Your SlideShare is downloading. ×
Ihs treatment2011
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Ihs treatment2011

472
views

Published on

Published in: Education, Health & Medicine

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
472
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. The department of internal medicine, clinical pharmacology and occupational diseases, BSMU, ChernivtsiThe treatment of IHD Eugene I. Shorikov, associate prof., PhD
  • 2. Pharmacological modification of the major determinants of myocardial O2 supply
  • 3. The clinical presentations of ischaemic heart disease• silent ischaemia• stable angina pectoris• unstable angina• myocardial infarction(MI)• heart failure• sudden death.
  • 4. AIMS of treatment of angina• To improve prognosis by preventing MI and sudden death• To minimize or abolish symptoms
  • 5. Indication For Revascularization
  • 6. Acute coronary syndrome• Patients with chest pain represent a very large proportionof all acute medical hospitalizations.• The leading symptom that initiates the diagnostic and therapeutic cascade is chest pain, but the classification of patients is based on the electrocardiogram (ECG).
  • 7. Acute coronary syndrome• Two categories of patients may be encountered:
  • 8. Acute coronary syndrome
  • 9. Acute coronary syndrome
  • 10. Acute coronary syndrome
  • 11. Long-term management of ACSPatients with NSTE-ACS after the initial phase carry a high risk ofrecurrence of ischaemic events. Therefore, active secondary prevention isan essential element of long-term management
  • 12. Long-term management of ACS
  • 13. Conclusion on management ACS
  • 14. Thank You